Donna F Vine Selected Research

11-octadecenoic acid (vaccenic acid)

4/2016	Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat.
8/2012	The intestinal bioavailability of vaccenic acid and activation of peroxisome proliferator-activated receptor-α and -γ in a rodent model of dyslipidemia and the metabolic syndrome.
7/2010	Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat.
1/2010	Vaccenic and elaidic acid modify plasma and splenocyte membrane phospholipids and mitogen-stimulated cytokine production in obese insulin resistant JCR: LA-cp rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Donna F Vine Research Topics

Disease

9	Cardiovascular Diseases (Cardiovascular Disease) 08/2020 - 10/2002
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014 - 09/2008
7	Obesity 01/2021 - 11/2008
7	Dyslipidemias (Dyslipidemia) 01/2021 - 11/2008
6	Insulin Resistance 01/2018 - 11/2008
4	Atherosclerosis 03/2014 - 10/2002
3	Short Bowel Syndrome 01/2018 - 01/2017
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2017 - 05/2013
3	Hyperlipidemias (Hyperlipidemia) 04/2016 - 08/2012
3	Inflammation (Inflammations) 04/2016 - 01/2010
2	Type 2 Diabetes Mellitus (MODY) 10/2012 - 07/2012
2	Hypertrophy 08/2012 - 09/2008
2	Body Weight (Weight, Body) 08/2010 - 11/2008
2	Sclerosis 08/2010 - 10/2007
2	Vascular Diseases (Vascular Disease) 08/2010 - 10/2007
1	Intestinal Failure 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Fibrosis (Cirrhosis) 09/2016
1	Choline Deficiency 10/2015
1	Hyperandrogenism 09/2014
1	Anorexia 07/2014
1	Starvation 07/2014
1	Hyperphagia (Overeating) 03/2014
1	Non-alcoholic Fatty Liver Disease 03/2014
1	Liver Failure 03/2014
1	Weight Loss (Weight Reduction) 05/2013
1	Hyperinsulinism (Hyperinsulinemia) 08/2010
1	Weight Gain 10/2007
1	Alzheimer Disease (Alzheimer's Disease) 06/2003

Drug/Important Bio-Agent (IBA)

8	LipidsIBA 01/2021 - 09/2008
8	CholesterolIBA 01/2020 - 10/2002
8	Insulin (Novolin)FDA Link 03/2017 - 10/2007
7	Lipoproteins (Lipoprotein)IBA 01/2021 - 10/2002
5	Apolipoprotein B-48IBA 01/2021 - 10/2002
5	Triglycerides (Triacylglycerol)IBA 01/2021 - 11/2009
4	Apolipoproteins B (ApoB)IBA 01/2021 - 01/2017
4	11-octadecenoic acid (vaccenic acid)IBA 04/2016 - 01/2010
3	ChylomicronsIBA 01/2018 - 09/2008
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	ApolipoproteinsIBA 08/2020 - 10/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 11/2008
2	Choline (Choline Chloride)IBA 10/2015 - 03/2014
2	Simvastatin (Zocor)FDA LinkGeneric 01/2014 - 10/2012
2	Conjugated Linoleic AcidsIBA 08/2012 - 07/2010
1	BilirubinIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018
1	Glucagon (Glukagon)FDA Link 04/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2017
1	Epidermal Growth Factor (EGF)IBA 04/2017
1	oxidized low density lipoproteinIBA 01/2017
1	Glucagon-Like Peptide 2IBA 01/2017
1	anandamide (arachidonylethanolamide)IBA 04/2016
1	N-acylethanolaminesIBA 04/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2016
1	Type 2 Angiotensin ReceptorIBA 09/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2014
1	Nonesterified Fatty Acids (NEFA)IBA 09/2014
1	Pharmaceutical PreparationsIBA 07/2014
1	Serotonin (5 Hydroxytryptamine)IBA 07/2014
1	NeuropeptidesIBA 03/2014
1	Neuropeptide YIBA 03/2014
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 03/2014
1	LDL Receptors (LDL Receptor)IBA 03/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Ezetimibe (Zetia)FDA Link 10/2012
1	BiglycanIBA 10/2012
1	Messenger RNA (mRNA)IBA 08/2012
1	Proteins (Proteins, Gene)FDA Link 08/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2012
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2011
1	HaptoglobinsIBA 08/2010
1	RimonabantIBA 08/2010
1	CytokinesIBA 01/2010
1	elaidic acidIBA 01/2010
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2010
1	Arginine (L-Arginine)FDA Link 10/2007
1	Inositol (Myoinositol)IBA 10/2007
1	SilicatesIBA 10/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2007
1	Amyloid beta-PeptidesIBA 06/2003
1	Proteoglycans (Proteoglycan)IBA 10/2002

Therapy/Procedure

1	Parenteral Nutrition 01/2018
1	Enteral Nutrition (Feeding, Tube) 01/2017
1	Therapeutics 01/2017
1	Complementary Therapies (Alternative Medicine) 09/2016
1	Aftercare (After-Treatment) 09/2014
1	Caloric Restriction 05/2013